People are also afraid of tests that involve MRI scans and biopsies. These are the reasons why we are working on developing a test procedure that estimates the risk of prostate cancer precisely ...

A global research team has discovered a breakthrough set of urine biomarkers for prostate cancer that outperform the ...

The study identified a set of biomarkers in urine that were able to indicate the presence and severity of prostate cancer with a high degree of precision ... Large-scale clinical trials are ...

Traditional methods like MRI are largely ... future of prostate cancer care. Using deep learning, Avenda Health software maps a patient's cancer in 3D, giving physicians precise information ...

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.